• CONTACT
  • NEWS & MEDIA
  • UPCOMING EVENTS
  • Canady Helios Cold Plasma
  • Canady Hybrid Plasma
    • Canady Hybrid Plasma Technology
    • Canady Plasma XL 1000 Smart Electrosurgical Generator
    • Canady Hybrid Plasma™ Scalpel
    • Canady Plasma Probes
  • Our Treatment
  • Science of Plasma
  • About Us
    • Message From CEO
    • Mission/Vision
    • Management Team
    • Company Milestones
  • Our Patients
    • PATIENT FOCUS
    • Clinical Trial

Scientific American Top Ten Emerging Technologies of 2019: Canady Cold Plasma

by PVA_Admin | Dec 20, 2019 | Cold Plasma Publications, Publications

Scientific American Top Ten Emerging Technologies of 2019: Canady Cold Plasma Mark Peplow PhD When a surgeon removes a tumor, some cancer cells may get left behind, threatening to seed another malignant growth. Researchers have just begun the first clinical trial of a...
Reduced Blood Loss With Use of Canady Hybrid Plasma Scalpel Compared With Bovie Electrocautery in the Resection of Soft-Tissue Sarcomas

Reduced Blood Loss With Use of Canady Hybrid Plasma Scalpel Compared With Bovie Electrocautery in the Resection of Soft-Tissue Sarcomas

by PVA_Admin | Dec 18, 2019 | Cold Plasma Publications, Publications

Reduced Blood Loss With Use of Canady Hybrid Plasma Scalpel Compared With Bovie Electrocautery in the Resection of Soft-Tissue Sarcomas Connor J. Wakefield, BS, Chris Culvern, MS, Matthew W. Colman, MD, Jerome Canady, MD, Steven Gitelis, MD, Alan T. Blank, MD, MS As...

US Medical Innovations Receives FDA 510(k) Clearance for the Canady Plasma Smart XL-1000 Generator

by PVA_Admin | Nov 25, 2019 | 2019 Press Release, Press Release

US Medical Innovations Receives FDA 510(k) Clearance for the Canady Plasma Smart XL-1000 Generator TAKOMA PARK, Md.–(BUSINESS WIRE)–US Medical Innovations, LLC (USMI), a Biomedical and Life Science subsidiary of US Patent Innovations, LLC (USPI) announced...

US Medical Innovations to Present at the Baird 2019 Global Healthcare Conference

by PVA_Admin | Aug 27, 2019 | 2019 Press Release, Press Release

US Medical Innovations to Present at the Baird 2019 Global Healthcare Conference TAKOMA PARK, MD.– US Medical Innovations, LLC (USMI), a U.S. FDA registered life science, biomedical and robotic device company (a subsidiary of US Patent Innovations, LLC), announced...

USMI and JCRI-ABTS Receive FDA Approval to Conduct the First U.S. Clinical Trial Using Cold Atmospheric Plasma for the Treatment of Cancer

by PVA_Admin | Jul 31, 2019 | 2019 Press Release, Press Release

USMI and JCRI-ABTS Receive FDA Approval to Conduct the First U.S. Clinical Trial Using Cold Atmospheric Plasma for the Treatment of Cancer TAKOMA PARK, Md.–(BUSINESS WIRE)–US Medical Innovations, LLC (USMI), a Biomedical and Life Science subsidiary of US...
« Older Entries
Next Entries »

Recent Posts

  • US Medical Innovations Secures FDA Clearance for Canady Helios Cold Plasma™ Ablation System
  • USMI TO DEBUT THE CANADY ROBOTIC AI SURGICAL SYSTEM AT THE FIRST GLOBAL SURGICAL ONCOLOGY SUMMIT JERUSALEM, ISRAEL JANUARY 2024
  • Groundbreaking Results Using Canady Helios™ Cold Plasma Treatment Published in MDPI Journal “Cancers”
  • The First Cold Atmospheric Plasma Phase I Clinical Trial for the Treatment of Advanced Solid Tumors: A Novel Treatment Arm for Cancer
  • USMI Receives FDA Approval for New Robotic Surgery Device – The Canady Flex RoboWrist™

Recent Comments

No comments to show.

CANADY HELIOS COLD PLASMA ›

CANADY HYBRID PLASMA ›

OUR TREATMENT ›

SCIENCE OF PLASMA ›

ABOUT US ›

OUR PATIENTS ›

NEWS & MEDIA ›

CONTACT USMI ›

Copyright © 2025 US Medical Innovations